Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.
BACKGROUND
Tissue factor (TF) is a transmembrane glycoprotein that, after binding to factor VII/VIIa, initiates the extrinsic coagulation pathway, resulting in thrombin generation and its sequelae. Thrombin has been shown to induce TF mRNA in endothelium, monocytes, and smooth muscle cells, further perpetuating the thrombogenic cycle. This study was designed to determine the effect of specific inhibition of thrombin by recombinant hirudin (r-hirudin) on TF distribution after balloon angioplasty in the cholesterol-fed rabbit femoral artery and porcine coronary artery models.


RESULTS
Thirty-five femoral arteries from 32 cholesterol-fed New Zealand White rabbits and 84 coronary arteries from 55 Yorkshire-Albino swine were studied by use of a recently developed in situ method of TF localization based on digoxigenin labeling of recombinant factor VIIa (Dig-VIIa), with correlative studies of TF immunoreactivity by use of anti-rabbit (AP-1) or anti-human (sTF) antibodies. At sites of balloon angioplasty in rabbit femoral or pig coronary arteries (double or single injury), TF-antibody and Dig-VIIa staining were noted in association with endothelial cells, smooth muscle cells, and foam cells and within the fibrous tissue matrix primarily of the adventitia and neointima. Staining was significantly greater after balloon angioplasty than in vessels that had not undergone angioplasty but was similar after single and double balloon injury. Animals treated with r-hirudin (rabbits, 1 mg/kg bolus plus 2-hour infusion; pigs, 1 mg/kg bolus plus 0.7 mg x kg(-1) x d(-1) infusion for 14 days with implantable pump) had diminished TF-antibody and Dig-VIIa staining 28 days after balloon angioplasty compared with controls (bolus heparin only). This effect was more prominent on the neointima and was more striking in the porcine than the rabbit model.


CONCLUSIONS
TF expression, persistent 1 month after balloon angioplasty in rabbit femoral arteries and porcine coronary arteries, is attenuated by specific thrombin inhibition with hirudin. These results suggest that thrombin inhibition, in addition to its effect on acute thrombus formation and its effect on luminal narrowing by plaque in experimental animals, may result in a prolonged reduction in thrombogenicity of the restenotic plaque through this effect on TF expression.
Gertz
S D
SD
Department of Anatomy and Cell Biology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. gertz@cc.huji.ac.il
Fallon
J T
JT
Gallo
R
R
Taubman
M B
MB
Banai
S
S
Barry
W L
WL
Gimple
L W
LW
Nemerson
Y
Y
Thiruvikraman
S
S
Naidu
S S
SS
Chesebro
J H
JH
Fuster
V
V
Sarembock
I J
IJ
Badimon
J J
JJ
D000800:Angioplasty, Balloon / Q000009:adverse effects*; D000818:Animals; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D003331:Coronary Vessels / Q000293:injuries* / Q000378:metabolism / Q000473:pathology; D004076:Digoxigenin; D015942:Factor VIIa / Q000378:metabolism; D005263:Femoral Artery / Q000293:injuries* / Q000378:metabolism / Q000473:pathology; D006629:Hirudins / Q000494:pharmacology*; D008297:Male; D011817:Rabbits; D011994:Recombinant Proteins; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors; D013925:Thromboplastin / Q000378:metabolism*; D017539:Tunica Intima / Q000378:metabolism*; D014947:Wounds and Injuries / Q000473:pathology
D002791:Cholesterol, Dietary; D006629:Hirudins; D011994:Recombinant Proteins; D013925:Thromboplastin; D015942:Factor VIIa; D013917:Thrombin; D004076:Digoxigenin